Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat severe asthma.
In a study of over 200 participants with severe asthma, the new treatment was shown to have improved asthma symptoms and lung function, while reducing the need for corticosteroids by up to 70%.
According to Statistics Canada, eight per cent of Canadians aged 12 or older – approximately 2.4 million people – have been diagnosed with asthma. Of that, approximately 25% are considered to be severe cases of asthma.
Current treatments for severe asthma often include high doses of corticosteroids, such as prednisone, to control exacerbations. Reducing the need for corticosteroids with alternative treatments is preferable, since these medications are associated with serious side effects from prolonged use – including multi-organ toxicities and immunosuppression.
Parameswaran Nair, professor of medicine at McMaster and staff respirologist at St. Joseph’s Healthcare Hamilton, along with a team of researchers found that an antibody called dupilumab is effective in treating severe asthma in place of high doses of prednisone.
The results were published in the New England Journal of Medicine, one of the world’s most influential medical publications.
Researchers sought participants who had been using oral corticosteroids (prednisone) to treat severe asthma for at least six months prior to the study. In addition to their standard regimen of corticosteroids, patients received either dupilumab or a placebo during the 24 week trial. The corticosteroid dose was gradually reduced during weeks four to 20, and maintained at a low level for the final four weeks.
“The ability of dupilumab to increase lung function as markedly as it did in this study, even in the face of [corticosteroid] withdrawal, indicates that it appears to be inhibiting key drivers of lung inflammation,” the researchers noted.
Dupilumab works to treat asthma by blocking two specific proteins (called interleukin-4 and interleukin-13) that are associated with inflammation of the airways.
This technique was based on Nair’s previous research, (published in the New England Journal of Medicine in 2009 and in 2017). Those studies found that blocking another protein, interleukin-5, allowed patients with high eosinophil levels in their blood and airways to reduce their corticosteroid dose. Eosinophils are a type of white blood cell involved with the production of interleukins. High eosinophil levels are directly linked to an increased risk of severe asthma.
Unlike the previous studies, dupilumab was shown to be effective regardless of patients’ eosinophil levels. Despite the reduced prednisone dose, patients in this study not only experienced a decrease in asthma exacerbations, but their lung function also improved significantly.
“Ultimately, our goal is to find new treatment pathways that allow us to circumvent the use of corticosteroids,” said Nair.
“Since dupilumab showed a significant improvement on asthma control regardless of eosinophil levels, we may be able to use this treatment for a wider range of patients than we previously thought possible. This might be due to the broad effects on inflammation in asthma of the two proteins that we were able to block with dupilumab. The treatment was not associated with any serious side effects.”
Learn more:Â Study Demonstrates New Treatment for Severe Asthma
The Latest on: Asthma
[google_news title=”” keyword=”asthma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Asthma
- Teenager dies of asthma attack after delay in sending ambulanceon May 12, 2024 at 7:04 pm
The call handler failed to clarify two answers about the teen's breathing and the family had to call back 20 minutes later, a report has found.
- Teen dies of asthma after ambulance call-taker incorrectly classified and recorded triage informationon May 12, 2024 at 7:00 pm
It took two calls from a desperate mother to emergency services and a 28-minute wait before paramedics arrived at the home of a teen who was suffering an asthma attack and deteriorating by the minute.
- Does Rain Improve Or Worsen Air Quality For People With Asthma Or Respiratory Conditions? A Review By Doctorson May 12, 2024 at 2:28 pm
India Rainfall can have both positive and negative effects on air quality. It can reduce air pollution by absorbing pollutants and settling down particulate matter, however, it can also cause pollen ...
- Is it Asthma or Allergies?on May 12, 2024 at 3:50 am
IN THIS MORNING’S MEDICAL ALERT, MAY IS ASTHMA AWARENESS MONTH. BUT HOW DO YOU KNOW IF IT’S ASTHMA OR JUST ALLERGIES? JOINING US LIVE THIS MORNING WITH MORE IS DOCTOR CHRISTY ALI WITH JOHNS HOPKINS ...
- OHSU doctor says rainy weather can help those with asthmaon May 10, 2024 at 11:15 pm
With the uptick in temperatures, many allergy sufferers see an increase in symptoms. Those with asthma may have to take more precautions on a daily basis.
- Chronic asthma could be caused by cell overcrowding in the airwayson May 10, 2024 at 8:30 am
Identifying drugs to reduce the excessive expulsion of cells in the lung lining could reduce the damage of chronic asthma.
- Study Offers Clues on Asthma Control for Patients With Concurrent Diabeteson May 9, 2024 at 9:00 pm
I n patients with asthma and type 2 diabetes, certain newer classes of antidiabetic agents were associated with a higher incidence of acute exacerbations when compared with metformin, a retrospective ...
- What Triggers Asthma?on May 9, 2024 at 5:00 am
Asthma is a chronic condition that causes inflammation and tightening of the airways which can cause symptoms like difficulty breathing, wheezing, and coughing. Asthma is a common condition and ...
- The 11 workers most at risk for developing asthma — did your job make the list?on May 7, 2024 at 6:47 am
A law firm that specializes in industrial disease cases is revealing the 11 types of employees it claims are at higher risk for asthma due to frequent exposure to irritants — including hairdressers, ...
via Bing News